Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.2B | 2.9B | 3.0B | 2.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.0B | 954M | 958M | 909M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.3B | 1.2B | 1.3B | 1.1B |
| Tax provision | 286M | 235M | 273M | 234M |
| Net income | 997M | 955M | 1.0B | 906M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 997M | 955M | 1.0B | 906M |
| Minority interests | 0 | 0 | 0 | 1M |
| Preferred stock dividends | — | — | — | — |